project id: TCGA-SKCM; case submitter id: TCGA-FS-A4FB; source center: 23; state: released; a260 a280 ratio: 1.84; normal tumor genotype snp match: Yes; ribosomal rna 28s 16s ratio: 1.12; rna integrity number: 7.5; age at index: 46; days to birth: -16896; days to death: 813; ethnicity: not hispanic or latino; gender: female; race: white; vital status: Dead; year of birth: 1963; year of death: 2011; age at diagnosis: 16896; ajcc pathologic m: M0; ajcc pathologic n: N1a; ajcc pathologic stage: Stage III; ajcc pathologic t: T2; ajcc staging system edition: 6th; classification of tumor: not reported; days to diagnosis: 0; icd 10 code: C77.9; last known disease status: not reported; morphology: 8720/3; primary diagnosis: Malignant melanoma, NOS; prior malignancy: no; prior treatment: No; progression or recurrence: not reported; site of resection or biopsy: Lymph node, NOS; synchronous malignancy: No; tissue or organ of origin: Skin, NOS; tumor grade: Not Reported; year of diagnosis: 2009; treatment or therapy: no; alcohol history: Not Reported; is ffpe: false; composition: Not Reported; initial weight: 70.0; oct embedded: false; preservation method: Unknown; sample id: 8ea3c94a-1c48-4358-88cb-6928cbb5b385; sample submitter id: TCGA-FS-A4FB-06A; portion id: d0c49370-6183-44a7-aba3-7e46a6348b23; portion submitter id: TCGA-FS-A4FB-06A-11; slide id: 35e93c29-f963-4149-9512-27744a18a35c; slide submitter id: TCGA-FS-A4FB-06A-01-TS1; percent lymphocyte infiltration: 0.0; percent monocyte infiltration: 0.0; percent necrosis: 0.0; percent neutrophil infiltration: 0.0; percent normal cells: 0.0; percent stromal cells: 0.0; percent tumor cells: 100.0; percent tumor nuclei: 98.0; section location: TOP;